Abstract:Background: Bone morphogenetic proteins (BMPs) are secreted ligands of the transforming growth factor-β (TGF-β) superfamily of proteins. BMP7 has been reported to traverse obesity and regulates appetite in the hypothalamus. However, whether central BMP9 regulates glucose metabolism and insulin sensitivity remains unclear. In this study, we focused on the impacts of central BMP-9 signaling and possible route of transmission. Methods: We performed intracerebroventricular (ICV) surgery and injected adenovirus expressing BMP9 (Ad-BMP9) or adenovirus encoding enhanced green fluorescence protein (Ad-GFP) into cerebral ventricle of mice. Then metabolic analyses, hyperinsulinemic-euglycemic clamp (HEC) and analysis of PIP3 formation were fulfilled. Real-time PCR and Western blot were performed to investigate potential pathway. Findings: We exhibited that hypothalamic BMP9 expression was downregulated in obese or insulin resistance (IR) mice. Overexpression of BMP9 in the hypothalamus reduced food intake, body weight, blood glucose, and elevated energy expenditure in high fat diet (HFD)-fed mice. Importantly, central treatment of BMP9 improved hepatic IR and inhibited hepatic glucose production (HGP) in mice fed with HFD. The increased hepatic insulin sensitivity and the related metabolic impacts by central BMP9 were blocked by ICV rapamycin injection (an inhibitor of the mTOR signaling). In addition, ICV BMP9 promoted the ability of insulin to activate the insulin receptor (InsR)/PI3K/Akt kinase pathway in hypothalamus. Interpretation: This study provided insight into the potential mechanism by which central BMP9 ameliorates glucose metabolism and IR by promoting the ability insulin to activate the mTOR/PI3K/Akt signaling in the hypothalamus. Funding Statement: This work was supported by grants from National Natural Science Foundation (No:81873658, 81670755), the Natural Science Foundation Project of CQ (No. cstc2015jcyjA10084 and cstc2013 jcyjA 10067) and the Science and Technology Key Program of Health Bureau of Chongqing (2015ZDXM038).Declaration of Interests: The authors have no conflict of interests to declare. Ethics Approval Statement: In the study, all kinds of treatments for mice were strictly carried out in accordance with the administrative animal management method of Chongqing Medical University, and at the same time, they met the relevant regulations of the Ethics Society of Chongqing Medical University.

BACH1 Controls Hepatic Insulin Signaling and Glucose Homeostasis in Mice

BACH1 deficiency prevents neointima formation and maintains the differentiated phenotype of vascular smooth muscle cells by regulating chromatin accessibility

Bach1: Function, Regulation, and Involvement in Disease

Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation

Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.

BACH1 impairs hepatocyte regeneration after hepatectomy with repeated ischemia/reperfusion by reprogramming energy metabolism and exacerbating oxidative stress

m6A-activated BACH1 exacerbates ferroptosis by epigenetic suppression HSPB1 in severe acute pancreatitis

Pathophysiological role of BACH transcription factors in digestive system diseases

Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1‐driven gluconeogenesis

Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2

Cardiac-specific BACH1 Ablation Attenuates Pathological Cardiac Hypertrophy by Inhibiting the Ang II Type 1 Receptor Expression and the Ca2+/CaMKII Pathway.

Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy

BACH1 changes microglial metabolism and affects astrogenesis during mouse brain development

Bach1 Induces Endothelial Cell Apoptosis and Cell-Cycle Arrest Through ROS Generation.

Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease

BMP9 Action in the Hypothalamus Suppresses Hepatic Glucose Production Through a Central PI3K/Akt /mtor Pathway

Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells.

Hepatitis B X-interacting protein promotes the formation of the insulin gene–transcribing protein complex Pdx-1/Neurod1 in animal pancreatic β-cells

Genome-Scale CRISPR Knockout Screening Identifies BACH1 as a Key Regulator of Aflatoxin B1-Induced Oxidative Damage

BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretion

Transcription Factor Tip27 Regulates Glucose Homeostasis and Insulin Sensitivity in A Pi3-Kinase/Akt-Dependent Manner in Mice